BiotechTube
Home/SarcoMed USA/Daniel Cartwright
DC

Daniel Cartwright

Chairman of the Board

SarcoMed USA

Therapeutic Areas

Pulmonary & RespiratoryImmunologyOncology

SarcoMed USA Pipeline

DrugIndicationPhase
SM001 (alidornase/Tigerase)Pulmonary SarcoidosisPre-clinical
No-alpha IL-2 MuteinCancerPre-clinical

Leadership Team at SarcoMed USA

BD
Brian Davies
Chief Executive Officer
IN
Ira N. Kalfus
Chief Medical Officer
View full SarcoMed USA profile